Sanofi India Limited has informed the Exchange regarding the Trading Window closure pursuant to SEBI (Prohibition of Insider Trading) Regulations, 2015

SANOFI · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reaction · full curve 14 horizons · vs prior close

-2.7%1-day move

₹3248.00

prior close

₹3249.50

base price

After-mkt

timing

5m10m15m30m1D2D3D4D5D7D15D1M2M3M

+1.8+2.7+2.9+2.6-2.7-1.3-0.1+0.4+2.6+5.3+10.3+5.5-2.1+2.9

Up moveDown movePending

AI summary

Sanofi India has informed BSE and NSE that its trading window will be closed from 1st April 2026 until 48 hours after the announcement of its financial results for the quarter ending 31st March 2026. This is a standard compliance measure under SEBI's Insider Trading Regulations and the company's internal code of conduct. Designated persons and insiders are restricted from trading in the company's shares during this period. The closure is specifically to prevent any insider trading ahead of the quarterly results declaration.

Likely market impact

This is a routine regulatory filing with no direct impact on the stock price or shareholders. Investors should note that quarterly results are expected to be announced sometime after 1st April 2026, which could be a catalyst for price movement.